Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India

Pallavi Madhiraju- August 24, 2024 0

Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections ... Read More

Sun Pharmaceutical’s GL0034 study reveals promising obesity treatment outcomes

Pallavi Madhiraju- June 24, 2024 0

Sun Pharmaceutical Industries Limited unveiled data from its Phase 1 study of GL0034 (Utreglutide), targeting obesity in adults. The findings, presented at the 84th American ... Read More

Sun Pharma reports positive results for MM-II injection in knee osteoarthritis trial

Pallavi Madhiraju- June 15, 2024 0

Sun Pharma and Moebius Medical Limited, an Israel-based company, showcased compelling data at the European League Against Rheumatism (EULAR) 2024 conference. The results demonstrated the ... Read More

Bayer and Sun Pharma join forces for new brand of Finerenone in India

Pallavi Madhiraju- January 17, 2024 0

In a significant development for the Indian healthcare sector, Sun Pharmaceutical Industries Limited and Bayer have announced a collaborative agreement to market and distribute a ... Read More

Sun Pharma secures marketing rights for stroke drug Tyvalzi from Pharmazz

Pallavi Madhiraju- September 15, 2023 0

Sun Pharmaceutical Industries Limited has entered into a license agreement with U.S.-based biopharmaceutical company Pharmazz Inc. for the commercialization of the first-in-class innovative drug, Tyvalzi ... Read More

Sun Pharma’s GL0034 yields promising results in two Phase 1 trials

Pallavi Madhiraju- June 24, 2023 0

Sun Pharmaceutical Industries has unveiled positive results from two Phase 1 studies assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of GL0034, a novel long-acting GLP-1 ... Read More

Sun Pharma gains Health Canada’s approval for WINLEVI for acne treatment

Pallavi Madhiraju- June 19, 2023 0

Sun Pharma Canada, a subsidiary of Sun Pharmaceutical Industries, has secured Health Canada's approval for their pioneering acne treatment, WINLEVI (clascoterone cream 1%). This marks ... Read More

MMP Industries bags packaging order from Sun Pharmaceutical

Pallavi Madhiraju- May 7, 2023 0

MMP Industries, a Nagpur-based manufacturer of aluminum powders, aluminum foils, and aluminum conductors, has bagged its first commercial order from Sun Pharmaceutical Industries for the ... Read More

Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise

Raghuram Kadari- January 20, 2023 0

India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More

Sun Pharma launches generic of breast cancer drug Palbociclib in India

Pallavi Madhiraju- January 11, 2023 0

Sun Pharmaceutical Industries (Sun Pharma) said that one of its fully-owned subsidiaries has launched the generic version of Pfizer-developed Palbociclib in India for patients with ... Read More